SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp.
GERN 1.365-0.4%Jan 30 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Curtis Frazier who wrote (247)8/18/1997 12:53:00 AM
From: Tummus1   of 3578
 
Curtis
This does not even come close to a cure for cancer.
The telo. discovery is significant from a scientific perspective but has no immediate commercial value. You have to remember that the mechanisms by which this enzyme affects cancer and aging are still theoretical. If these mechanisms bear out (after years of research) then the enzyme can be a target for a drug. Such a drug will be developed by any number of major drug comapnies out there. Maybe with or without GERN. Best case scenario for GERN is that they will have an edge targeting this enzyme (providing it really is a major step in regulating tumors or aging) and can have a collaborative agreement with a drug company. By the way the aging angle is real thin. Not that telomerase could not be a component in cell senesence but it is unlikely to be a "master" regulator of aging.
I should say that I got my PhD in molecular biology from Harvard Medical School in '92 and my field of expertise is DNA replication Specifically, studying reverse transcriptase of which telomerase is related. I say this not to brag (because the degree has been a recipe for indentured servitude) but because I am much less knowledgeable about investing than about science and so I am happy tobe able to contribute when I see gross distortions about miracle discoveries either in the press or on SI. Of course, I wish I had the sense,or lack there of, to buy GERN Friday AM and sell in the PM. But I won't be buying Monday.
TW
PS. All of the managers of biotech mutual funds are completely aware of all of these limitations of this discovery.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News